Transcriptional Regulation of Stem Cell and Cancer Stem Cell Metabolism

被引：15
作者：
Alptekin A. [1 ,2 ]
Ye B. [1 ]
Ding H.-F. [1 ,2 ,3 ]
机构：
[1] Georgia Cancer Center, Augusta University, Augusta, 30912, GA
[2] Department of Biochemistry and Molecular Biology, Medical College of Georgia, Augusta University, Augusta, 30912, GA
[3] Department of Pathology, Medical College of Georgia, Augusta University, Augusta, 30912, GA
来源：
Current Stem Cell Reports | 2017年 / 3卷 / 1期
基金：
美国国家卫生研究院;
关键词：
Cancer stem cells; Glycolysis; Metabolism; Mitochondria; Oxidative phosphorylation; Stem cells; Transcription;
D O I：
10.1007/s40778-017-0071-y
中图分类号：
学科分类号：
摘要：
Purpose of Review: Metabolism is increasingly recognized as a major player in control of stem cell function and fate. How stem cell metabolism is established, maintained, and regulated is a fundamental question of biology and medicine. In this review, we discuss major metabolic programs in stem cells and cancer stem cells, with a focus on key transcription factors that shape the stem cell metabolic phenotype. Recent Findings: Cancer stem cells primarily use oxidative phosphorylation for energy generation, in contrast to normal stem cells, which rely on glycolytic metabolism with the exception of mouse embryonic stem cells. Transcription factors control the metabolic phenotype of stem cells by modulating the expression of enzymes and thus the activity of metabolic pathways. It is evident that HIF1α and PGC1α function as master regulators of glycolytic and mitochondrial metabolism, respectively. Summary: Transcriptional regulation is a key mechanism for establishing specific metabolic programs in stem cells and cancer stem cells. © 2017, Springer International Publishing AG.
引用
收藏
页码：19 / 27
页数：8
相关论文
共 98 条
[1]  
De Los A.A., Ferrari F., Xi R., Fujiwara Y., Benvenisty N., Deng H., Et al., Hallmarks of pluripotency, Nature, 525, 7570, pp. 469-478, (2015)
[2]  
Weissman I.L., Anderson D.J., Gage F., Stem and progenitor cells: origins, phenotypes, lineage commitments, and transdifferentiations, Annu Rev Cell Dev Biol, 17, pp. 387-403, (2001)
[3]  
Thomson J.A., Itskovitz-Eldor J., Shapiro S.S., Waknitz M.A., Swiergiel J.J., Marshall V.S., Et al., Embryonic stem cell lines derived from human blastocysts, Science, 282, 5391, pp. 1145-1147, (1998)
[4]  
Evans M.J., Kaufman M.H., Establishment in culture of pluripotential cells from mouse embryos, Nature, 292, 5819, pp. 154-156, (1981)
[5]  
Martin G.R., Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells, Proc Natl Acad Sci U S A, 78, 12, pp. 7634-7638, (1981)
[6]  
Takahashi K., Yamanaka S., Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors, Cell, 126, 4, pp. 663-676, (2006)
[7]  
Takahashi K., Tanabe K., Ohnuki M., Narita M., Ichisaka T., Tomoda K., Et al., Induction of pluripotent stem cells from adult human fibroblasts by defined factors, Cell, 131, 5, pp. 861-872, (2007)
[8]  
Copley M.R., Beer P.A., Eaves C.J., Hematopoietic stem cell heterogeneity takes center stage, Cell Stem Cell, 10, 6, pp. 690-697, (2012)
[9]  
Bond A.M., Ming G.L., Song H., Adult mammalian neural stem cells and neurogenesis: five decades later, Cell Stem Cell, 17, 4, pp. 385-395, (2015)
[10]  
Fialkow P.J., Clonal origin of human tumors, Biochim Biophys Acta, 458, 3, pp. 283-321, (1976)
12345678910